Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator
CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has launched its … continue reading "Neuromodulation specialist CVRx Launches new Barostim NEO2™ Implantable Pulse Generator"
Читать дальше...